For Boston Scientific, Ashley oversees all communications and marketing activities spanning two businesses and five franchises. Activities include national consumer campaigns, healthcare professional campaigns, messaging and positioning, and content development.
Recently, Ashley helped guide Alder BioPharmaceuticals, Inc. in building the market and preparing for an FDA approval and launch for its migraine infusion drug. This included both corporate and product communications, messaging and positioning, spokesperson training and subsequent CEO roadshows, social media channel development, data announcements and the acquisition of the company in November 2019.
Ashley also oversaw the strategic development of multiple consumer campaigns for DePuy Synthes Companies that received national media, as well as received multiple awards including a CLIO Healthcare Award. In her work for Amylin Pharmaceuticals, Ashley pioneered the development of a one-of-a-kind healthcare professional education program that won the accolades of the American Diabetes Association as well as American Association of Diabetes Educators.
Ashley is a graduate of California State University, Fullerton and holds a Bachelor of Arts degree in communication with an emphasis in public relations as well as a minor in business administration.